Hint mode is switched on Switch off

Cara Therapeutics, ordinary share
CARA, US1407551092

Add a stock to WL
Choose all Reset all
Tvardi Therapeutics, сountry — USA
01/01/2025 stock stopped trading due to affiliation to Tvardi Therapeutics, ordinary share
No trading data
Data display in a chart | table
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
No data
from
to
ADD-IN
Cbonds add-in API
bond data api
Authorization required
You need to request access
More than 2,500 records have been found, please specify your request
No data for the selected period

Upgrade to Premium features

Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market

Get access
Welcome to Cbonds

  • Full access to the largest bond database

    Bond parameters,
    prospectuses

  • Seamless
    Data export

    Analyze the data in the most efficient way

  • Bond pricing

    Current & historical quotes from 400+ stock exchanges & OTC market

  • Smart risk assessment

    Credit ratings, financial reports

Get access

Latest quotes

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Issuer

Profile
Tvardi Therapeutics is a clinical-stage, biopharmaceutical company focused on the development of novel, oral small molecule therapies targeting STAT3 to treat fibrosis-driven diseases with significant unmet need.
  • Issuer
  • Full borrower / issuer name
    Tvardi Therapeutics, Inc.
  • Industry
    Pharmaceutical Preparation and Biotechnology

Placement data

  • Placement type
    IPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    CARA
  • Placement
    31.01.2014
  • Lock up period
    180
  • Number of papers
    5,000,000
  • Volume of raised funds
    55 mln USD
  • Final placement price
    11 USD
  • Price change since placement date
    -100%
  • By capitalization
    240.27 mln USD
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    CARA
  • Placement
    30.07.2015
  • Lock up period
    180
  • Number of papers
    3,763,440
  • Volume of raised funds
    70 mln USD
  • Placement share
    14.15%
  • Final placement price
    18.6 USD
  • Price change since placement date
    -100%
  • By capitalization
    494.77 mln USD
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    CARA
  • Placement
    31.03.2017
  • Lock up period
    180
  • Number of papers
    4,450,000
  • Volume of raised funds
    80.1 mln USD
  • Placement share
    14.02%
  • Final placement price
    18 USD
  • Price change since placement date
    -100%
  • By capitalization
    571.44 mln USD
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    CARA
  • Placement
    24.07.2019
  • Lock up period
    180
  • Number of papers
    5,000,000
  • Volume of raised funds
    127.4 mln USD
  • Placement share
    11.22%
  • Final placement price
    25.48 USD
  • Price change since placement date
    -100%
  • By capitalization
    1,135.77 mln USD
Other placements of the issuer Hide

IFRS/US GAAP reports

2025
I q eng
2024
I q eng
II q eng
III q eng
IV q eng
2023
I q eng
II q eng
III q eng
IV q eng
2022
I q eng
II q eng
III q eng
IV q eng
2021
I q eng
II q eng
III q eng
IV q eng
2020
I q eng
II q eng
III q eng
IV q eng
2019
I q eng
II q eng
III q eng
IV q eng
2018
I q eng
II q eng
III q eng
IV q eng
2017
I q eng
II q eng
III q eng
IV q eng
2016
I q eng
II q eng
III q eng
IV q eng
2015
I q eng
II q eng
III q eng
IV q eng
2014
IV q eng
Show all Hide

Indicators

News

06/03/2026 Tvardi Therapeutics: Other Events
14/10/2025 Recent Market Shifts and Their Impact on Company Stock Prices
14/08/2025 Tvardi Therapeutics: Results Of Operations And Financial Condition, Financial Statements And Exhibits
08/07/2025 Tvardi Therapeutics: Departure Of Directors Or Certain Officers, Election Of Directors, Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers
06/06/2025 Tvardi Therapeutics: Other Events, Financial Statements And Exhibits
All organization news

Other stocks and deposit receipts

Holders

Industry Leaders

Registration is required to get access.